EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

Yusuke Isshiki, Xi Chen, Matt Teater, Ioannis Karagiannidis, Henna Nam, Winson Cai, Cem Meydan, Min Xia, Hao Shen, Johana Gutierrez, Vigneshwari Easwar Kumar, Sebastián E. Carrasco, Madhu M. Ouseph, Samuel Yamshon, Peter Martin, Ofir Griess, Efrat Shema, Patrizia Porazzi, Marco Ruella, Renier J. Brentjens, Giorgio Inghirami, Roberta Zappasodi, Amy Chadburn, Ari M. Melnick, Wendy Béguelin

Open source

DOI: 10.1016/j.ccell.2024.11.006
Published: 2025-01
Container: Cancer Cell
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ccell.2024.11.006,
  title = {EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function},
  author = {Yusuke Isshiki and Xi Chen and Matt Teater and Ioannis Karagiannidis and Henna Nam and Winson Cai and Cem Meydan and Min Xia and Hao Shen and Johana Gutierrez and Vigneshwari Easwar Kumar and Sebastián E. Carrasco and Madhu M. Ouseph and Samuel Yamshon and Peter Martin and Ofir Griess and Efrat Shema and Patrizia Porazzi and Marco Ruella and Renier J. Brentjens and Giorgio Inghirami and Roberta Zappasodi and Amy Chadburn and Ari M. Melnick and Wendy Béguelin},
  year = {2025},
  journal = {Cancer Cell},
  doi = {10.1016/j.ccell.2024.11.006},
  url = {https://doi.org/10.1016/j.ccell.2024.11.006}
}

RIS

TY  - JOUR
TI  - EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
AU  - Yusuke Isshiki
AU  - Xi Chen
AU  - Matt Teater
AU  - Ioannis Karagiannidis
AU  - Henna Nam
AU  - Winson Cai
AU  - Cem Meydan
AU  - Min Xia
AU  - Hao Shen
AU  - Johana Gutierrez
AU  - Vigneshwari Easwar Kumar
AU  - Sebastián E. Carrasco
AU  - Madhu M. Ouseph
AU  - Samuel Yamshon
AU  - Peter Martin
AU  - Ofir Griess
AU  - Efrat Shema
AU  - Patrizia Porazzi
AU  - Marco Ruella
AU  - Renier J. Brentjens
AU  - Giorgio Inghirami
AU  - Roberta Zappasodi
AU  - Amy Chadburn
AU  - Ari M. Melnick
AU  - Wendy Béguelin
PY  - 2025
JO  - Cancer Cell
DO  - 10.1016/j.ccell.2024.11.006
UR  - https://doi.org/10.1016/j.ccell.2024.11.006
ER  -

APA

Isshiki, Y., Chen, X., Teater, M., Karagiannidis, I., Nam, H., Cai, W., Meydan, C., Xia, M., Shen, H., Gutierrez, J., Kumar, V. E., Carrasco, S. E., Ouseph, M. M., Yamshon, S., Martin, P., Griess, O., Shema, E., Porazzi, P., Ruella, M., Brentjens, R. J., Inghirami, G., Zappasodi, R., Chadburn, A., Melnick, A. M., & Béguelin, W. (2025). EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function. Cancer Cell. https://doi.org/10.1016/j.ccell.2024.11.006

Source records

crossref · retrieved 2026-09-26T19:12:22.287Z